Topoisomerase I mediated TA cloning
From OpenWetWare
Jump to navigationJump to search
See also TOPO TA cloning.
Topoisomerase site
Topoisomerase
Topoisomerase recognition site
---------
Topoisomerase nick site
|
V
5' C C C T T N N N N N N
3' G G G A A N N N N N N
^
|
Restriction enzyme must nick here
Offset nicking enzyme
- Nt.BstNB I: offset nicking enzyme from NEB.
Nt.BstNB I recognition site
---------
Nt.BstNB I nick site
|
V
5' G A G T C N N N N N 3'
3' C T C A G N N N N N 5'
Site for topoisomerase-mediated cloning
Upstream of the BioBricks prefix
Topoisomerase recognition site
---------
|
V
5' C C C T T N N N G A C T C 3'
3' G G G A A N N N C T G A G 5'
^
|
---------
Nt.BstNB I recognition site
Downstream of BioBricks suffix
Nt.BstNB I recognition site
---------
|
V
5' G A G T C N N N A A G G G 3'
3' C T C A G N N N T T C C C 5'
^
|
---------
Topoisomerase recognition site
Possible enzymes to generate 3' T overhang
None of these enzymes will work because it appears as if the topoisomerase enzyme needs some duplex DNA in order to function.
Each can accommodate the topoisomerase site CCCTT
- BmrI
- offset cutter that leaves 3' single base overhang
- two sites in sopC (incD) repeat region of BBa_I50000
- no sites in BBa_I50020
- no sites in BBa_P1010, BBa_P1000, BBa_B0055, BBa_B0054
- pretty high activity in all 4 NEB buffers
- BciVI
- offset cutter that leaves 3' single base overhang
- no sites in BBa_I50000
- one site in BBa_I50020
- no sites in BBa_P1010, BBa_P1000, BBa_B0055, BBa_B0054
- Austin says this is a very bad enzyme.
- XcmI
- long recognition sequence with internal N9 that leaves 3' single base overhang
- no sites in BBa_I50000
- no sites in BBa_I50020
- no sites in BBa_P1010, BBa_P1000, BBa_B0055, BBa_B0054
- 100% activity only in NEBBuffer 2
Topoisomerase sites internal to vector components are not important because topoisomerase only operates near double stranded breaks.
Based on the preexistence of sites in the designed parts, XcmI looks like a good bet but it is not as robust to buffer conditions as BmrI.
Topoisomerase I
Most of the papers reference Topoisomerase I from vaccinia. It seems to be available commercially at Epicentre. html protocol
- Anselm Levskaya - I've gotten Vaccinia WR strain isolate and am presently cloning the topoisomerase IB gene out. Classically this is purified by using a phosphocellulose column but I'm going to just try a His-Tagged approach since it's a small protein.
Vector preparation
Reference
- Vectors pcDNA3.1/GS and pYES2/GS
v
HindIII site
-----------
5' N N N N N A A G C T T N N N N N 3'
3' N N N N N T T C G A A N N N N N 5'
-----------
HindIII site
^
- Cut with HindIII
5' C C C T T A
3' G G G A A T T C G A
A G C T T A A G G G 3'
A T T C C C 5'
- Ligate on oligos (TOPO-H and TOPO-4)
- TOPO-H destroys the HindIII site
- TOPO-4 provides recessed end
- In the drawings below, " | " refers to a break in the backbone on that strand.
TOPO-H oligo
-----------------------------------------------
5' N N N N N A A G C T C G C C C T T A T T C C G A T A G T G
3' N N N N N T T C G A G C G G G A
------- -----------
HindIII overhang TOPO-4 oligo
TOPO-4 oligo HindIII overhang
------------ -------
A G G G C G A G C T T N N N N N 3'
G T G A T A C C T T A T T C C C G C T C G A A N N N N N 5'
------------------------------------------------
TOPO-H oligo
- Purify and cut again with HindIII to remove circular vector.
- Add TOPO-5 oligo and topoisomerase.
- Vaccinia topoisomerase I cleaves after and remains covalently attached to second T in CCCTT sequence.
Topoisomerase nick
v
TOPO-H oligo
-------------------------------------------------
5' N N N N N A A G C T C G C C C T T A T T C C G A T A G T G 3'
3' N N N N N T T C G A G C G G G A | A T A A G G C T A T C A C A A C 5'
------- ----------- -------------------------------
HindIII overhang TOPO-4 oligo TOPO-5 oligo
TOPO-5 oligo TOPO-4 oligo HindIII overhang
------------------------------- ------------ -------
C A A C A C T A T C G G A A T A | A G G G C G A G C T T N N N N N 3'
G T G A T A C C T T A T T C C C G C T C G A A N N N N N 5'
------------------------------------------------
TOPO-H oligo
^
Topoisomerase nick
- Add TOPO-10X stop buffer
- Purify away free oligonucleotides and unbound topoisomerase I
Questions
- The authors add a primer TOPO-5 into the mix when they add the isomerase. It seems like this primer should not be necessary. Does the topoisomerase I "need" some duplex DNA extending out from where it will nick in order to cleave the backbone? Austin thinks most enzymes do need duplex DNA.
- How much of a performance hit will we take if we don't do all the purification steps they do ... it kind of seems like a lot of work (even though you only have to prep the vector once for multiple reactions).
- Can a restriction enzyme and topoisomerase I cleave simultaneously or will they occlude one another?
- Does TOPO TA cloning have a better success rate than TA cloning or is it just simpler?
Notes
This approach to topoisomerase I mediated cloning has NOT been tested. This project is still a work in progress.
Additional references
Topoisomerase I
- Shuman S and Moss B. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7478-82. DOI:10.1073/pnas.84.21.7478 |
- Shuman S and Prescott J. Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. J Biol Chem. 1990 Oct 15;265(29):17826-36.
- Shuman S. DNA strand transfer reactions catalyzed by vaccinia topoisomerase I. J Biol Chem. 1992 Apr 25;267(12):8620-7.
- Shuman S. Recombination mediated by vaccinia virus DNA topoisomerase I in Escherichia coli is sequence specific. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10104-8. DOI:10.1073/pnas.88.22.10104 |
- Shuman S. Two classes of DNA end-joining reactions catalyzed by vaccinia topoisomerase I. J Biol Chem. 1992 Aug 25;267(24):16755-8.
- Shuman S. DNA strand transfer reactions catalyzed by vaccinia topoisomerase I. J Biol Chem. 1992 Apr 25;267(12):8620-7.
- Shuman S. Novel approach to molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase. J Biol Chem. 1994 Dec 23;269(51):32678-84.